SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-110094
Filing Date
2024-04-24
Accepted
2024-04-24 16:10:53
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-24

Document Format Files

Seq Description Document Type Size
1 ARS d790300dars.pdf ARS 4963734
  Complete submission text file 0001193125-24-110094.txt   6831553
Mailing Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38890 | Film No.: 24870687
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)